Auriga Reiterates a 'Buy' on Thermo Fisher Scientific (TMO); Year Ends on Strong Note; 2012 Guidance Looks Good
TMO Hot Sheet
Rating Summary:6 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Auriga reiterates a 'Buy' on Thermo Fisher Scientific (NYSE: TMO) price target of $65.00.
Auriga analyst said, "Yesterday, TMO reported 4Q11 sales of $3.13B (+15%; 5% org, 1% acq . and 0 % F/X) and non-GAAP EPS of $1.18 (+23% Y/Y). Revenue and EPS were above consensus and our estimates. Organic revenue growth of 5% was ahead of our expectations (2%) as new product launches, solid demand in emerging markets and a rebound in Academic/Government (~24% of sales) all helped. Global demand remains steady with continued strength in industrial, applied and clinical diagnostic markets, but weakness in Academic and Government will likely continue throughout 2012. Overall, TMO's diverse end markets should help offset the lingering weakness within Academic/Government."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $54.71 yesterday, with a 52 week range of $43.06-$65.86.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Auriga analyst said, "Yesterday, TMO reported 4Q11 sales of $3.13B (+15%; 5% org, 1% acq . and 0 % F/X) and non-GAAP EPS of $1.18 (+23% Y/Y). Revenue and EPS were above consensus and our estimates. Organic revenue growth of 5% was ahead of our expectations (2%) as new product launches, solid demand in emerging markets and a rebound in Academic/Government (~24% of sales) all helped. Global demand remains steady with continued strength in industrial, applied and clinical diagnostic markets, but weakness in Academic and Government will likely continue throughout 2012. Overall, TMO's diverse end markets should help offset the lingering weakness within Academic/Government."
For an analyst ratings summary and ratings history on Thermo Fisher Scientific click here. For more ratings news on Thermo Fisher Scientific click here.
Shares of Thermo Fisher Scientific closed at $54.71 yesterday, with a 52 week range of $43.06-$65.86.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Canaccord Genuity maintains a 'Buy' on Auxilium Pharmaceuticals (AUXL); Bumping Guidance on Testim Partnership with GSK
- Goldman Sachs Adds AmerisourceBergen (ABC) to Conviction Buy, Removes McKesson (MCK)
- Nomura Securities Maintains a 'Neutral' on Yahoo! (YHOO); Monetizing Alibaba
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
